Status:
COMPLETED
Examining the Impact of High-protein Oral Supplement on Protein Status of Adults on Peritoneal Dialysis
Lead Sponsor:
University of Florida
Conditions:
Renal Failure
Protein-Energy Malnutrition
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a 6-month prospective interventional clinical trial designed to evaluate the impact of whey protein isolate oral supplement on protein status. Differences in protein status will be evaluated w...
Eligibility Criteria
Inclusion
- 18 years old or older
- diagnosed with stage 5 Chronic Kidney Disease for at least 3 months prior to the starting date of the trial
- on peritoneal dialysis at least three months prior to the starting date of the trial
- can provide signed informed consent
- have no dietary restriction
- no food allergies
- no chewing/swallowing difficulties.
Exclusion
- not meeting the above
- pregnant/lactating as either self-reported or determined by the medical director
- Chronic Kidney Disease patient stages 1-4.
- Chronic Kidney Disease patient undergoing hemodialysis.
- use of other protein supplement
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06154161
Start Date
March 1 2024
End Date
September 1 2024
Last Update
April 4 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32606
2
UF Health Dialysis Center
Gainesville, Florida, United States, 32611